Chinese vaccine maker Sinovac Biotech said on Thursday it had received regulatory approval for a freeze-dried human rabies vaccine that uses a serum-free, animal component-free manufacturing process and supports a shortened four-dose vaccination schedule recommended by the World Health Organization.